ArticleLa Radiologia medica2026
Stepwise minimally invasive management of cesarean scar pregnancy: retrospective clinical and fertility outcomes.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the effectiveness and safety of the intra-arterial infusion of methotrexate (MTX) followed by uterine arteries embolization (UAE) in women with cesarean scar pregnancy (CSP) in which serum β-HCG levels remained elevated and the gestational sac showed no significant reduction 2 weeks after systemic administration of MTX. MATERIAL AND
methodsTwenty-one patients with CSP were enrolled in the study. Technical success, clinical success and complication rates were assessed. Technical success was defined as complete bilateral intra-arterial MTX infusion and successful UAE. Primary clinical outcomes included reduction of gestational sac size, absence of active vaginal re-bleeding, and normalization or steady decline of β-HCG values. Secondary clinical outcomes comprised pregnancy termination, gestational sac expulsion, and reduced or absent bleeding during suction curettage of the uterine cavity. Additionally, the need for uterine cavity revision, time to menstruation recovery, and outcome of subsequent pregnancies were evaluated.
resultsTechnical success, primary clinical outcome, and pregnancy termination were achieved in all cases (100%). Spontaneous expulsion of the gestational sac occurred in five patients (23.9%), while the remaining patients underwent ultrasound-guided suction curettage of the uterine cavity. Two patients (9.5%) required additional hysteroscopy. No major complications were registered. Pain was effectively managed in all patients within 24 h. Menstrual function resumed within 3 months in all women. Among the 12 patients (91.6%) who wished to conceive again, 11 (91.6%) achieved a successful pregnancy.
conclusionIntra-arterial MTX and UAE, following systemic MTX, appear to be a safe and effective treatment for CSP.
Indexed as
Identifiers
41670889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.